Hudock Inc’s GenMark Diagnostics, Inc GNMK Stock Holding History

Hudock Inc’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,200	Closed	-$13K	–	750
2019 Q3	$13K	Buy	2,200 +1,100	+100%	+$6.86K	﹤0.01%	401
2019 Q2	$7K	Buy	+1,100	New	+$7.75K	﹤0.01%	463

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hudock Inc's GNMK Position: Q4 2019 in Review

Hudock Inc sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2019, closing a stake of 2,200 shares — an estimated $13K sold.

Hudock Inc first reported a position in GNMK in Q2 2019 and held it in 2 quarters. The position peaked at $13K in Q3 2019. 111 funds tracked by Wall St. Rank hold GNMK as of Q4 2019.

Hudock Inc reported no remaining GenMark Diagnostics, Inc position as of Q4 2019 after selling out during the quarter.
Hudock Inc sold 2,200 GenMark Diagnostics, Inc shares in Q4 2019, an estimated $13K.
Hudock Inc first reported a position in GenMark Diagnostics, Inc in Q2 2019 and held it in 2 quarters.
Hudock Inc's GenMark Diagnostics, Inc position peaked at $13K in Q3 2019.
111 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2019.

Based on Hudock Inc's 13F filing for Q4 2019, filed 21 Jan 2020.